Cypherpunk Technologies INC. (CYPH) — 8-K Filings

All 8-K filings from Cypherpunk Technologies INC.. Browse 24 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (24)

Cypherpunk Technologies Inc. Files 8-K — Dec 30, 2025 Risk: low
Cypherpunk Technologies Inc. filed an 8-K on December 30, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure
8-K Filing — Dec 16, 2025
Cypherpunk Technologies Inc. Enters Material Definitive Agreement — Nov 20, 2025 Risk: medium
On November 19, 2025, Cypherpunk Technologies Inc. entered into a material definitive agreement. The company, formerly known as Leap Therapeutics, Inc. and Dekk
8-K Filing — Nov 18, 2025
Leap Therapeutics Files 8-K with Key Corporate Updates — Nov 12, 2025 Risk: medium
On November 11, 2025, Leap Therapeutics, Inc. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, rep
Leap Therapeutics Files 8-K — Oct 20, 2025 Risk: low
On October 20, 2025, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific
Leap Therapeutics Files 8-K: Material Agreement, Equity Sales — Oct 9, 2025 Risk: medium
On October 6, 2025, Leap Therapeutics, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities a
Leap Therapeutics Files 8-K Report — Oct 6, 2025 Risk: low
On October 6, 2025, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific
Leap Therapeutics Faces Delisting Concerns — Sep 11, 2025 Risk: high
Leap Therapeutics, Inc. filed an 8-K on September 11, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The earl
Leap Therapeutics Files 8-K on Financials — Aug 14, 2025 Risk: low
On August 14, 2025, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as w
Leap Therapeutics Files 8-K on Executive Changes & Corporate Actions — Jun 23, 2025 Risk: medium
On June 23, 2025, Leap Therapeutics, Inc. filed an 8-K report detailing several key events. The company reported on cost associated with exit or disposal activi
Leap Therapeutics Files 8-K on Financials — May 13, 2025 Risk: low
Leap Therapeutics, Inc. filed an 8-K on May 13, 2025, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhibi
Leap Therapeutics Files 8-K on Financials and Operations — Mar 26, 2025 Risk: low
On March 26, 2025, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along
Leap Therapeutics Faces Delisting Concerns — Mar 17, 2025 Risk: high
Leap Therapeutics, Inc. filed an 8-K on March 17, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The earliest
Leap Therapeutics Files 8-K Report — Jan 28, 2025 Risk: low
On January 28, 2025, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific
Leap Therapeutics Files 8-K on Financials — Nov 13, 2024 Risk: low
On November 13, 2024, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as
Leap Therapeutics Files 8-K Report — Sep 30, 2024 Risk: low
On September 30, 2024, Leap Therapeutics, Inc. filed an 8-K report detailing other events and financial statements. The company, incorporated in Delaware, is ba
Leap Therapeutics Files 8-K on Financials — Aug 12, 2024 Risk: low
On August 12, 2024, Leap Therapeutics, Inc. filed an 8-K report detailing its financial results and operations. The company, incorporated in Delaware with its p
Leap Therapeutics Files 8-K on Security Holder Vote — Jul 8, 2024 Risk: low
On July 2, 2024, Leap Therapeutics, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not specify
Leap Therapeutics Files 8-K with Financial Updates — May 13, 2024 Risk: low
On May 13, 2024, Leap Therapeutics, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibi
Leap Therapeutics Files 8-K: Material Agreement & Equity Sales — Apr 11, 2024 Risk: medium
On April 10, 2024, Leap Therapeutics, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The compan
Leap Therapeutics Files 8-K on Financials — Mar 18, 2024 Risk: low
On March 18, 2024, Leap Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along
Leap Therapeutics Files 8-K for 'Other Events' on Jan 23, 2024 — Jan 23, 2024
Leap Therapeutics, Inc. filed an 8-K on January 23, 2024, to report an "Other Event" and "Financial Statements and Exhibits." This filing indicates that the com
Leap Therapeutics Confirms Nasdaq Listing & Admin Details — Jan 16, 2024
Leap Therapeutics, Inc. filed an 8-K on January 16, 2024, to update its registration information, specifically noting its Common Stock, par value $0.001, is tra

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX